Estados financieros detallados de LENZ Therapeutics, Inc. (LENZ): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 90.1%, margen operativo -6.3%, margen neto -5.9%.
Al precio actual de $4.14, LENZ presenta beneficios negativos (P/E no significativo) y un ROE del -53.39%. La capitalización bursátil es de $130M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | $15.0M | 0 | 0 | $19.1M |
| Coste de Ventas | 0 | $121000 | $734000 | 0 | 0 | $58000 | $705000 |
| Beneficio Bruto | 0 | -$121000 | -$734000 | $15.0M | 0 | -$58000 | $18.4M |
| I+D | 0 | $9.1M | $37.9M | $21.1M | $59.5M | $29.8M | $18.7M |
| Generales y Administrativos | $29000 | $4.3M | $21.8M | $4.4M | $12.9M | $28.8M | $90.9M |
| Gastos Operativos | $29000 | $13.4M | $59.7M | $25.5M | $72.4M | $58.6M | $109.5M |
| Beneficio Operativo | -$29000 | -$13.5M | -$60.4M | -$10.5M | -$72.4M | -$58.6M | -$91.1M |
| EBITDA | $142860 | -$68.2M | -$70.0M | -$10.5M | -$70.1M | -$49.7M | -$81.3M |
| Gastos por Intereses | $80000 | $40000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$109000 | -$68.4M | -$70.8M | -$10.5M | -$70.1M | -$49.8M | -$81.6M |
| Impuestos | 0 | 0 | 0 | $347000 | -$179000 | $1000 | $502000 |
| Beneficio Neto | -$109000 | -$68.4M | -$70.8M | -$10.8M | -$70.0M | -$49.8M | -$82.1M |
| BPA | $-0.01 | $-8.24 | $-8.54 | $-12.89 | $-15.30 | $-2.34 | $-2.85 |
| BPA Diluido | $-0.01 | $-8.24 | $-8.54 | $-12.89 | $-15.30 | $-2.34 | $-2.85 |
| Acciones en Circulación (Diluidas) | $8.3M | $8.3M | $8.3M | $7.8M | $8.1M | $21.3M | $28.8M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $12.5M | $1.6M | $1.9M | $5.5M |
| Beneficio Bruto | $12.4M | $1.1M | $714000 | $5.2M |
| Beneficio Operativo | -$18.9M | -$38.5M | -$44.1M | -$34.2M |
| EBITDA | -$16.6M | -$35.8M | -$41.4M | -$31.8M |
| Beneficio Neto | -$16.7M | -$35.9M | -$41.5M | -$31.9M |
| BPA | $-0.59 | $-1.16 | $-1.32 | $-1.02 |
| BPA Diluido | $-0.59 | $-1.16 | $-1.32 | $-1.02 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $6000 | $19.8M | $18.3M | $44.4M | $35.1M | $20.2M | $25.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | $30.7M | $188.9M | $267.2M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | $2.4M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $6000 | $21.1M | $18.3M | $46.6M | $67.2M | $211.9M | $301.4M |
| Inmovilizado Material | 0 | $1.5M | $10000 | $279000 | $372000 | $2.0M | $1.9M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $6000 | $22.6M | $18.3M | $47.0M | $70.4M | $215.3M | $305.9M |
| Cuentas por Pagar | 0 | $630000 | $460000 | $4.8M | $5.7M | $4.3M | $4.2M |
| Deuda a Corto | $2.2M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.2M | $32.0M | $1.3M | $9.5M | $18.5M | $10.4M | $21.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.2M | $32.4M | $32.5M | $71.1M | $163.1M | $11.2M | $21.5M |
| Reservas | -$2.2M | -$70.6M | -$14.5M | -$25.3M | -$95.2M | -$145.0M | -$227.1M |
| Patrimonio Neto | -$2.2M | -$9.8M | -$14.2M | -$24.2M | -$92.7M | $204.1M | $284.3M |
| Deuda Total | $2.2M | 0 | 0 | $250000 | $329000 | $1.4M | $815000 |
| Deuda Neta | $2.2M | -$19.8M | -$18.3M | -$44.2M | -$65.5M | -$207.6M | -$291.5M |
| Capital Circulante | -$2.2M | -$10.9M | $17.1M | $37.1M | $48.7M | $201.5M | $280.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $25.4M | $25.2M | $24.8M | $24.2M |
| Activos Totales | $210.7M | $305.9M | $272.5M | $236.6M |
| Pasivos Totales | $16.8M | $21.5M | $26.0M | $17.3M |
| Patrimonio Neto | $193.9M | $284.3M | $246.5M | $219.3M |
| Deuda Total | $954000 | $815000 | $673000 | $122000 |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$109000 | -$68.4M | -$70.8M | -$101.1M | -$70.0M | -$49.8M | -$82.1M |
| Amortizaciones | 0 | $121000 | $734000 | $8.3M | $15000 | $58000 | -$3.1M |
| Compensación en Acciones | 0 | 0 | 0 | 0 | $1.3M | $6.4M | $12.5M |
| Cambio en Capital Circulante | $10000 | $1.7M | -$2.5M | -$7.2M | $9.4M | -$13.1M | $3.3M |
| Flujo de Caja Operativo | -$19000 | -$8.7M | -$52.9M | -$88.0M | -$60.4M | -$59.4M | -$69.2M |
| Inversiones (CapEx) | 0 | -$1.5M | -$5.7M | -$6.6M | -$30000 | -$468000 | -$827000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | -$79000 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$19000 | -$10.3M | -$58.6M | -$94.6M | -$60.4M | -$59.9M | -$70.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$8.6M | -$33.0M | -$33.6M | -$38.7M |
| Inversiones (CapEx) | -$439000 | -$38000 | -$18000 | -$16000 |
| Flujo de Caja Libre | -$9.0M | -$33.1M | -$33.6M | -$38.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.5M | $3.7M | 0 | $4.5M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | -100.0% | | |
| Crecimiento Beneficio Neto (anual) | | -62627.5% | -3.5% | +84.7% | -547.2% | +28.9% | -65.0% |
| Crecimiento BPA (anual) | | -62800.8% | -3.6% | -51.0% | -18.7% | +84.7% | -21.8% |
| Cambio en Acciones (anual) | | +0.0% | -0.1% | -5.4% | +3.9% | +161.3% | +35.4% |
| Crecimiento FCF (anual) | | -53931.6% | -470.7% | -61.4% | +36.1% | +0.9% | -16.9% |
| Margen Bruto | | | | 100.0% | | | 96.3% |
| Margen Operativo | | | | -69.9% | | | -477.5% |
| Margen EBITDA | | | | -69.7% | | | -426.1% |
| Margen Neto | | | | -72.1% | | | -430.3% |
| Margen FCF | | | | -630.5% | | | -366.7% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -3.3% | 0.3% | -0.0% | -0.6% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.00 | $-1.24 | $-7.07 | $-12.06 | $-7.42 | $-2.81 | $-2.43 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $8.3M | $8.3M | $8.3M | $7.8M | $8.1M | $21.3M | $28.8M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -53.39% |
| Rentabilidad sobre capital invertido | -61.84% |
| Rentabilidad sobre activos | -53.26% |
| Margen bruto | 90.14% |
| Margen operativo | -631.70% |
| Margen neto | -586.74% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 13.55 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -6683.97 | -10.63 | -6.89 | -1.22 | -0.81 | -12.34 | -5.61 |
| P/VC | -327.54 | -74.13 | -34.30 | -5.10 | -1.09 | 3.01 | 1.62 |
| P/V | 0.00 | 0.00 | 0.00 | 8.21 | 0.00 | 0.00 | 24.15 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% | 0.0% | 96.3% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | -69.9% | 0.0% | 0.0% | -477.5% |
| Margen Neto | 0.0% | 0.0% | 0.0% | -72.1% | 0.0% | 0.0% | -430.3% |